EXHIBIT 31.1

                     CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                           PURSUANT TO RULE 13a-14(a) OF THE
                      SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
                                AS ADOPTED PURSUANT TO
                     SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Raymond P.L. Cannefax, certify that:

1.       I have reviewed this annual report on Form 10-KSB of Paradigm Medical
         Industries, Inc.;

2.       Based on my knowledge, this annual report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this annual report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this annual report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of the registrant as of, and for, the periods presented in
         this annual report;

4.       The registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
         registrant and have:

         (a) Designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under the Company's
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within those entities, particularly during the period in
         which this annual report is being prepared;

         (b) Evaluated the effectiveness of the registrant's disclosure controls
         and procedures and presented in this annual report the Company's
         conclusions about the effectiveness of the disclosure controls and
         procedures, as of the end of the period covered by this annual report
         based on such evaluation; and

         (c) Disclosed in this annual report any change in the registrant's
         internal control over financial reporting that occurred during
         registrant's most recent fiscal quarter (the registrant's fourth fiscal
         quarter in the case of an annual report) that has materially affected,
         or is reasonably likely to materially affect, registration's internal
         control over financial reporting; and

5.       The registrant's other certifying officers and I have disclosed, based
         on the Company's most recent evaluation of internal control over
         financial reporting, to the registrant's auditors and the audit
         committee of registrant's board of directors (or persons performing the
         equivalent functions):

         (a) All significant deficiencies and material weaknesses in the design
         or operation of internal control over financial reporting which are
         reasonably likely to adversely affect the registrant's ability to
         record, process, summarize and report financial information; and

         (b) Any fraud, whether or not material, that involves management or
         other employees who have a significant role in the registrant's
         internal control over financial reporting.


Date: April 14, 2006

                                                /s/ Raymond P.L. Cannefax
                                               ---------------------------
                                               Raymond P.L. Cannefax
                                               President and Chief
                                               Executive Officer